D.E. Shaw & Co’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
D.E. Shaw & Co's FLNA Position: Q3 2026 in Review
D.E. Shaw & Co sold out of Filana Therapeutics (FLNA) in Q3 2026, closing a stake of 485,025 shares — an estimated $577K sold.
D.E. Shaw & Co first reported a position in FLNA in Q2 2013 and held it in 30 quarters. The position peaked at $5.13M in Q2 2021. 79 funds tracked by Wall St. Rank hold FLNA as of Q3 2026.
- D.E. Shaw & Co reported no remaining Filana Therapeutics position as of Q3 2026 after selling out during the quarter.
- D.E. Shaw & Co sold 485,025 Filana Therapeutics shares in Q3 2026, an estimated $577K.
- D.E. Shaw & Co first reported a position in Filana Therapeutics in Q2 2013 and held it in 30 quarters.
- D.E. Shaw & Co's Filana Therapeutics position peaked at $5.13M in Q2 2021.
- 79 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.